You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

glucosylceramide

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gaucher Disease Type 1, Gaucher Disease Type 3 Trial in Worldwide (venglustat (GZ402671), imiglucerase)

Active, not recruiting
  • Gaucher Disease Type 1
  • Gaucher Disease Type 3
  • New Haven, Connecticut
  • +6 more
Aug 9, 2022

Tay-Sachs Disease Sandhoff Disease Trial in Worldwide (venglustat GZ402671, )

Active, not recruiting
  • Tay-Sachs Disease Sandhoff Disease
  • venglustat GZ402671
  • placebo
  • Los Angeles, California
  • +23 more
Jan 31, 2022

Autosomal Dominant Polycystic Kidney Trial in Melbourne (AL01211 or Placebo (Part A), AL01211 or Placebo (Part B))

Active, not recruiting
  • Autosomal Dominant Polycystic Kidney
  • AL01211 or Placebo (Part A)
  • AL01211 or Placebo (Part B)
  • Melbourne, Victoria, Australia
    Nucleus Network
May 16, 2022

Gaucher Disease, Type 1 Trial in Jerusalem (Ambroxol)

Active, not recruiting
  • Gaucher Disease, Type 1
  • Jerusalem, Israel
    Shaare Zedek Medical Center
May 24, 2022

Neurofibromatosis 1, NF1, Neurofibromatosis Type 1 Trial in Chicago

Recruiting
  • Neurofibromatosis 1
  • +2 more
    • Chicago, Illinois
      Ann & Robert H. Lurie Children's Hospital of Chicago
    Mar 11, 2022

    Gaucher Disease, Type 1, Gaucher Disease, Type 3 Trial in Beijing (Low-dose CAN103, High-dose CAN103)

    Recruiting
    • Gaucher Disease, Type 1
    • Gaucher Disease, Type 3
    • Low-dose CAN103
    • High-dose CAN103
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jul 25, 2022

    Skin Condition Trial in Cheras, Petaling Jaya (Rice ceramide supplementation)

    Completed
    • Skin Condition
    • Rice ceramide supplementation
    • Cheras, Kuala Lumpur, Malaysia
    • +1 more
    Sep 27, 2022

    Lyso-Gb1 as a Long-term Prognostic Biomarker in Gaucher Disease

    Completed
    • Lysosomal Storage Diseases
    • +2 more
      • Tirana, Albania
      • +7 more
      May 27, 2021

      Hereditary Spastic Paraparesis Trial in Pisa (Miglustat 100 MG)

      Completed
      • Hereditary Spastic Paraparesis
      • Miglustat 100 MG
      • Pisa, PI, Italy
        IRCCS Fondazione Stella Maris
      Apr 1, 2022

      Parkinson Disease, GBA Gene Mutation Trial in Milan, Naples, Pavia (Ambroxol Hydrochloride, Placebo)

      Recruiting
      • Parkinson Disease
      • GBA Gene Mutation
      • Ambroxol Hydrochloride
      • Placebo
      • Milan, Italy
      • +2 more
      Mar 10, 2022

      Determine Mutations in Gaucher Gene in Idiopathic Parkinson's

      Completed
      • Parkinson Disease
      • Idiopathic Parkinson Disease
        • Bad Neustadt An Der Saale, Germany
        • +14 more
        Apr 8, 2021

        Parkinson's Disease Trial in Worldwide (venglustat GZ/SAR402671, Placebo)

        Terminated
        Has Results
        • Parkinson's Disease
        • venglustat GZ/SAR402671
        • Placebo
        • Scottsdale, Arizona
        • +51 more
        May 3, 2022

        Skin Pathology Assessment With Optical Technologies

        Recruiting
        • Atopic Dermatitis Eczema
        • Skin imaging and Skin biopsy
        • Sheffield, South Yorkshire, United Kingdom
          Sheffield Dermatology Research, University of Sheffield Medical
        Jun 8, 2022

        Fabry Disease Trial in Worldwide (GZ/SAR402671)

        Completed
        Has Results
        • Fabry Disease
        • Atlanta, Georgia
        • +6 more
        Feb 26, 2021

        Polycystic Kidney, Autosomal Dominant Trial in Worldwide (Venglustat GZ402671, Placebo)

        Terminated
        Has Results
        • Polycystic Kidney, Autosomal Dominant
        • Birmingham, Alabama
        • +94 more
        Feb 1, 2023

        Fabry Disease Trial in Worldwide (GZ/SAR402671)

        Completed
        Has Results
        • Fabry Disease
        • Atlanta, Georgia
        • +7 more
        Nov 26, 2019

        Gaucher Disease Trial in Taipei (Miglustat, ERT)

        Unknown status
        • Gaucher Disease
        • Taipei, Taiwan
          National Taiwan University Hospital
        Mar 28, 2019

        ERT on Immune Aspects and Bone Involvement in Gaucher Disease

        Unknown status
        • Gaucher Disease
          • Fairfax, Virginia
            O&O Alpan, LLC
          Aug 12, 2019

          Gaucher Disease, Type 1, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease Trial in Worldwide (Eliglustat

          Completed
          Has Results
          • Gaucher Disease, Type 1
          • +4 more
          • Eliglustat tartrate
          • New York, New York
          • +16 more
          Dec 22, 2016

          Characterize Effect of Pharmacological Chemicals on Blood From

          Completed
          • Gaucher Disease
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Jun 30, 2017

            Gaucher Disease Trial in Bethesda, London (OGT 918)

            Completed
            • Gaucher Disease
            • OGT 918
            • Bethesda, Maryland
            • +1 more
            Jun 30, 2017

            Gaucher Disease, Type 1 Trial in Worldwide (Eliglustat tartrate, Placebo)

            Completed
            Has Results
            • Gaucher Disease, Type 1
            • Eliglustat tartrate
            • Placebo
            • San Francisco, California
            • +17 more
            Jan 17, 2017

            Gaucher Disease, Type 1 Trial in Worldwide (Eliglustat tartrate, Imiglucerase)

            Completed
            Has Results
            • Gaucher Disease, Type 1
            • Beverly Hills, California
            • +33 more
            Oct 11, 2016

            Gaucher Disease Trial in Worldwide (Eliglustat tartrate)

            Completed
            Has Results
            • Gaucher Disease
            • Eliglustat tartrate
            • San Diego, California
            • +45 more
            Dec 12, 2016

            Gaucher Disease Type I, Cerebroside Lipidosis Syndrome, Clucocerebrosidase Deficiency Disease Trial in Coral Springs (Cerezyme

            Completed
            • Gaucher Disease Type I
            • +4 more
            • Cerezyme (imiglucerase for injection)
            • Coral Springs, Florida
              (unnamed)
            Mar 4, 2015